Formestane, a steroidal aromatase inhibitor after failure of non-steroidal aromatase inhibitors (anastrozole and letrozole): Is a clinical benefit still achievable?
Titel:
Formestane, a steroidal aromatase inhibitor after failure of non-steroidal aromatase inhibitors (anastrozole and letrozole): Is a clinical benefit still achievable?
Auteur:
Carlini, P. Frassoldati, A. De Marco, S. Casali, A. Ruggeri, E.M. Nardi, M. Papaldo, P. Fabi, A. Paoloni, F. Cognetti, F.